SER - PRICE - Serina Therapeutics, Inc.

Serina Therapeutics, Inc. (SER) develops unique POZ polymer systems for the precise transport of medications to the brain to combat dementia and Parkinson's disease. This chart reflects the current share price on GURU.Markets at 2.10, illustrating the position of a B2B biotech firm that optimizes the release of substances into the bloodstream. The company is currently deploying its available capital toward intensive R&D to create neurological solutions.

The closing price captures the final market equilibrium of supply and demand, determining the current value per unit of capital and the total market capitalization of Serina Therapeutics, Inc. (SER). By analyzing the history of market value, an investor can see how geopolitical instability and logistical disruptions in the supply of polymers for neurotherapy pressure quotes, transforming the operational risks of clinical trials into specific market volatility.